{"title": "University of Chicago Medicine to begin testing another COVID-19 vaccine", "author": "Lisa Schencker", "url": "https://www.chicagotribune.com/coronavirus/ct-coronavirus-vaccine-trial-university-chicago-janssen-20201102-wi6jqgje4rgmxaeyvrrfnxyh74-story.html", "hostname": "chicagotribune.com", "description": "University of Chicago Medicine will soon begin testing another potential COVID-19 vaccine, and is looking for up to 2,000 people to enroll in the phase three clinical trial.", "sitename": "Chicago Tribune", "date": "2020-11-02", "cleaned_text": "University of Chicago Medicine will soon begin testing another potential COVID-19 vaccine, and is looking for up to 2,000 adults to enroll in the phase three clinical trial. The trial is designed to evaluate the safety and efficacy of a single dose of a vaccine produced by Janssen Pharmaceutical Companies of Johnson & Johnson. The trial began enrolling 60,000 people across the world in September. It's one of [a handful of potential vaccines](https://www.chicagotribune.com/coronavirus/ct-coronavirus-covid-vaccine-development-20200820-dvix66lbenaqxolc5ngxatk52q-story.html) now in advanced clinical trials in the U.S. \"We are looking for individuals from all walks of life to participate in this study,\" said trial leader Dr. Habibul Ahsan, The international trial of the Janssen vaccine was temporarily paused in October after one participant developed an unexplained illness. \"Such pauses are not uncommon in vaccine trials, and late last week the FDA approved the resumption of the trial after an independent committee found the vaccine did not cause the illness,\" University of Chicago Medicine leaders wrote in an email sent Monday to faculty, staff and students. This is the second COVID-19 vaccine trial University of Chicago Medicine has offered. The health system is also participating in the Moderna COVE trial. To participate in the Janssen trial and future research, people can join [UChicago Medicine's registry](https://nam02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcovidvaccinestudies.uchicago.edu%2F&data=04%7C01%7Clschencker%40chicagotribune.com%7C01e1a7fc2926464b75f108d87f651e36%7Cf7da0482aed242fa80233b240fb6598d%7C0%7C0%7C637399419571053987%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=s38gTHLgwWIKPsT5WNQQ0q60K%2B7RfrIz0Y0wN4VpCoY%3D&reserved=0). Other large hospital systems in Chicago are taking part in COVID-19 vaccine trials, including the [University of Illinois at Chicago](https://www.chicagotribune.com/coronavirus/ct-coronavirus-uic-vaccine-trial-covid-19-20200615-yr47lc6tizalbgzva3deadndxy-story.html), which is part of the [Moderna trial](https://www.chicagotribune.com/coronavirus/ct-covid-uic-vaccine-trial-20200824-ebv3frrbdvgpdbe22tionn4vfq-story.html), and Northwestern Medicine, which is part of a trial of the AstraZeneca Oxford vaccine. The AstraZeneca Oxford vaccine trial was temporarily paused in September after participants became ill, but that trial resumed in the U.S. in October after the FDA said it was safe to do so, AstraZeneca said in a news release. "}